Cutaneous manifestations associated with immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block key mediators of tumor-mediated immune evasion. The frequency of its use has increased rapidly and has extended to numerous cancers. ICIs target immune checkpoint molecules, such as programmed cell death protein 1 (PD-1), PD li...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Tomoya, Yamaguchi, Yukie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986601/
https://www.ncbi.nlm.nih.gov/pubmed/36891313
http://dx.doi.org/10.3389/fimmu.2023.1071983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986601/
https://www.ncbi.nlm.nih.gov/pubmed/36891313
http://dx.doi.org/10.3389/fimmu.2023.1071983

Ejemplares similares